Koers XsunX Inc OTC Bulletin Board
Aandelen
US98385L1026
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,17 mln. 2,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -924K | Nettowinst (verlies) 2023 | -4 mln. -3,7 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,41 mln. 1,3 mln. | Nettoschuld 2023 | 2,36 mln. 2,18 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,16
x | K/w-verhouding 2023 |
-0,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,82% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 10-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 18-03-22 |
John Cassarini
CHM | Chairman | 57 | 14-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,52% | 48,16 mld. | |
-1,11% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+10,12% | 25,59 mld. | |
-22,92% | 18,96 mld. | |
+8,17% | 12,92 mld. | |
+29,18% | 12,03 mld. | |
-1,80% | 11,77 mld. |